These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13264317)

  • 1. Prostatic carcinoma: treatment of advanced cases with intravenous diethylstilbestrol diphosphate.
    FLOCKS RH; MARBERGER H; BEGLEY BJ; PRENDERGAST LJ
    J Urol; 1955 Oct; 74(4):549-51. PubMed ID: 13264317
    [No Abstract]   [Full Text] [Related]  

  • 2. Regression of prostatic cancer metastasis by high doses of diethylstilbestrol diphosphate.
    Susan LP; Roth RB; Adkins WC
    Urology; 1976 Jun; 7(6):598-601. PubMed ID: 936380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytopenia during diethylstilbestrol diphosphate (stilphostrol) infusion for carcinoma of the prostate.
    Nachtsheim DA; McPherson RA; Pollen JJ; Schmidt JD
    Prostate; 1980; 1(1):105-9. PubMed ID: 7279796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of diethylstilbestrol diphosphate on serum and tissue ribonuclease levels in prostatic carcinoma.
    Erkan I; Ciliv G; Remzi D
    J Surg Oncol; 1982 Sep; 21(1):65-9. PubMed ID: 7109641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogen therapy--high-dose intravenous diethylstilbestrol diphosphate therapy for advanced or hormone refractory prostate cancer].
    Nakagawa M
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():199-204. PubMed ID: 12599571
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diethylstilbestrol diphosphate in prostate cancer therapy].
    DRUCKREY H; KAISER K
    Dtsch Med Wochenschr; 1956 Jul; 81(27):1084-6. PubMed ID: 13344071
    [No Abstract]   [Full Text] [Related]  

  • 7. [High-dose intravenous diethylstilbestrol diphosphate therapy for hormone refractory prostate cancer].
    Honda M; Umeda H; Yoshida K
    Nihon Rinsho; 1998 Aug; 56(8):2145-9. PubMed ID: 9750524
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioimmunoassay of diethylstilbestrol in plasma of patients with prostatic carcinoma.
    Usui T; Nakamura K; Osumi T; Ishibe T; Kitano T; Kambegawa A; Miyachi Y
    Arch Androl; 1984; 12(2-3):243-9. PubMed ID: 6508431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability, distribution and pharmacokinetics of diethylstilbestrol converted from diethylstilbestrol diphosphate in patients with prostatic cancer.
    Nakamura K
    Hiroshima J Med Sci; 1986 Dec; 35(4):325-38. PubMed ID: 3570844
    [No Abstract]   [Full Text] [Related]  

  • 10. Diethylstilbestrol-diphosphate-induced disseminated intravascular coagulation in prostatic carcinoma.
    Cornfield DB; Rossman RE
    South Med J; 1982 Feb; 75(2):248-9. PubMed ID: 7058376
    [No Abstract]   [Full Text] [Related]  

  • 11. Diethylstilboestrol diphosphate, honvan (ST 52-asta), in intravenous tumour-specific chemotherapy of metastatic carcinoma of the prostate.
    HANSEN CC
    Acta Chir Scand; 1958 Apr; 114(5):398-413. PubMed ID: 13532319
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells.
    Schulz P; Bauer HW; Brade WP; Keller A; Fittler F
    Cancer Res; 1988 May; 48(10):2867-70. PubMed ID: 2834049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diethylstilbestrol diphosphate on activity of 5 alpha-reductase in human prostate.
    Usui T; Ishibe T; Nakamura K; Mizutani M; Yasukawa A
    Arch Androl; 1987; 19(3):229-35. PubMed ID: 2461177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation.
    Ferro MA
    Urol Clin North Am; 1991 Feb; 18(1):139-43. PubMed ID: 1992567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications.
    Citrin DL; Elson P; Kies MS; Lind R
    Am J Med; 1984 May; 76(5):787-93. PubMed ID: 6539069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraparesis due to metastatic prostatic cancer effectively treated with a high dose of diethylstilbestrol diphosphate: a case report.
    Wakisaka M; Takagishi H
    Hinyokika Kiyo; 1993 Nov; 39(11):1055-8. PubMed ID: 8266876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
    Citrin DL; Kies MS; Wallemark CB; Khandekar J; Kaplan E; Camacho F; Lind R
    Cancer; 1985 Aug; 56(3):457-60. PubMed ID: 4005808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hormonal therapy with high-dose diethylstilbestrol diphosphate (DES-DP) intravenous infusion plus vindesine (VND) for the treatment of advanced prostatic carcinoma: a controlled study.
    Cervellino JC; Araujo CE; Pirisi C; Podskubka O; Morera E
    J Surg Oncol; 1990 Apr; 43(4):250-3. PubMed ID: 2182945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor-inhibiting effect of diethylstilbestrol and its diphosphate on the Nb-H and Nb-R prostatic carcinomas of the rat.
    Schneider MR; Humm A; Graf AH
    J Cancer Res Clin Oncol; 1990; 116(2):159-67. PubMed ID: 2324159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.